OBJECTIVE: Brain oedema is a major cause of clinical deterioration and death following brain trauma; cellular mechanisms involved in its development remain elusive. This study investigated the role of extracellular matrix metalloproteinase inducer (EMMPRIN) in brain oedema. METHODS: The monofilament puncture model was used to induce subarachnoid haemorrhage. Adult male Sprague-Dawley rats were divided into five groups (n = 20 per group): sham-operated, sacrificed immediately after surgery (sham group); sacrificed 12, 24 or 72 h after subarachnoid haemorrhage induction (SAH-12, SAH-24 and SAH-72 groups, respectively); treated with EMMPRIN inhibitor immediately after subarachnoid haemorrhage, sacrificed at 24 h (SAHinhibition group). Mean brain water content, and EMMPRIN mRNA and protein levels, were determined. RESULTS: Compared with the sham group, mean brain water content, EMMPRIN mRNA and protein levels in the SAH-12, SAH-24 and SAH-72 groups increased rapidly and significantly (maximal at 24 h). EMMPRIN inhibition significantly reduced mean brain water content and EMMPRIN mRNA and protein levels in the SAH-inhibition group, compared with the SAH-24 group. CONCLUSIONS: EMMPRIN upregulation may be important in the formation of brain oedema; inhibition of EMMPRIN activity may provide a potential approach to reduce oedema after subarachnoid haemorrhage.
Introduction
There has been a large number of clinical and experimental studies on the pathophysiology of subarachnoid haemorrhage, which is closely related to cerebral circulation, neuronal function, intracranial pressure and cerebral vasospasm. 1 -3 The role of brain oedema in subarachnoid haemorrhage has, however, rarely been investigated. Evidence suggests that brain a Y Tu, J Fu and J Wang contributed equally to this work. Y Tu, J Fu, J Wang et al. EMMPRIN in brain oedema oedema is a major cause of clinical deterioration and death following brain trauma as it increases intracranial pressure, impairs cerebral perfusion and oxygenation, and contributes to additional ischaemic injury. 4, 5 Because increasing numbers of patients with ruptured cerebral aneurysms undergo early surgery, it is becoming more important to understand brain oedema as a complication in patients with subarachnoid haemorrhage.
Cellular mechanisms involved in brain oedema formation following subarachnoid haemorrhage remain unclear, however.
Matrix metalloproteinases (MMP), a family of zinc-dependent proteolytic enzymes, have the ability to break down basal membrane and connective tissue. 6 Gelatinase A (MMP-2) and gelatinase B (MMP-9) are able to digest type IV collagen, laminin and fibronectin, which are major components of the basal lamina around cerebral blood vessels. 7, 8 Research has indicated that MMP-9 plays an important role in ischaemic microvascular damage. 9,10 MMP-9 has also been shown to contribute to brain extravasation and oedema in mice with fulminant hepatic failure. 11 Investigation of gelatinases in a rodent model of intracerebral haemorrhage showed that levels of MMPs were significantly increased, and that the administration of a synthetic MMP inhibitor significantly reduced brain water content, after an injection of bacterial collagenase into the brain. 12 MMP-9 has been shown to be involved in thrombolysis-associated haemorrhagic transformation after embolic focal cerebral ischaemia in rats. 13, 14 These studies suggest that MMPs play key roles in various models of brain injury.
Extracellular matrix metalloproteinase inducer (EMMPRIN), previously termed cellderived collagenase stimulatory factor (also known as basigin, CD147, or human leucocyte activation-associated M6 antigen) is one of the molecules involved in regulation of the expression of MMP genes; it is a surface molecule on tumour cells that stimulates nearby fibroblasts to produce MMP-1, -2 and -3. 15 -17 The cDNA for human EMMPRIN encodes a 269-amino acid residue polypeptide including a signal peptide of 21 amino acid residues, a 185-amino acid extracellular domain consisting of two regions characteristic of the immunoglobulin (Ig)G superfamily, followed by a 24amino acid residue transmembrane domain and a 39-amino acid cytoplasmic domain. 18 The EMMPRIN sequence is identical to that of the species homologues of mouse basigin and the chicken blood-brain barrier-specific HT7 molecule, known as neurothelin. 19, 20 Based on these data, it was hypothesized that EMMPRIN may be involved in the formation and progression of brain oedema after subarachnoid haemorrhage, through MMP upregulation.
The aim of the present study was to determine the temporal profile of EMMPRIN expression, its role in brain oedema formation and the effect of EMMPRIN inhibition on the formation of brain oedema in a rodent model of subarachnoid haemorrhage.
Materials and methods

ANIMALS
Animals were housed in facilities accredited by the International Council for Laboratory Animal Science 21 and the study was approved by and conducted in accordance with the Ethics Committee of Tangdu Hospital, Xi'an, China.
A total of 100 male Sprague-Dawley rats (3 -4 months old), each weighing 300 -350 g, were purchased from the Experimental Animal Centre of The Fourth Military Y Tu, J Fu, J Wang et al.
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Medical University, Xi'an, China. Rats were housed five per cage with free access to food and water, and kept under conditions of constant temperature (mean ± SD 22 ± 2°C) and humidity (mean ± SD 50% ± 5%), with a standard 12-h light/12-h dark cycle.
CHEMICALS AND REAGENTS
All chemicals were of analytical reagent grade. Before the experiment, all vessels and pipette tips were submerged in strong nitric acid (16 mol/l) for 24 h, then washed with ultrapure water. The water used was purified in a Milli-Q ® Integral Water Purification System (Millipore, Billerica, MA, USA).
INDUCTION OF ANIMAL MODEL AND RANDOMIZATION
The monofilament puncture model was used to induce subarachnoid haemorrhage, according to the description of Yan et al.; 22 haemorrhage was confirmed at autopsy in each rat. Sham-operated rats underwent the same procedure, except that the suture was advanced distally into the internal carotid artery and withdrawn once resistance was felt. Physiological parameters (including blood gases, blood pH, haematocrit, blood glucose concentration and body temperature) were maintained within normal ranges at the time of subarachnoid haemorrhage modelling.
A monoclonal antibody to EMMPRIN was used as an EMMPRIN inhibitor. One group of rats received treatment with 3 mg/kg anti-EMMPRIN monoclonal antibody (clone 1G6.2; Chemicon International, Temecula, CA, USA) intravenously (i.v.), immediately after modelling. Control IgG, with no immunoreactivity to EMMPRIN, was administered at equivalent dosages and times in all other groups apart from the sham group.
The 100 rats were divided into five groups (n = 20 per group): sham-operated rats, sacrificed immediately after surgery (sham group); rats sacrificed 12 h after subarachnoid haemorrhage modelling (SAH-12 group); rats sacrificed 24 h after modelling (SAH-24 group); rats sacrificed 72 h after modelling (SAH-72 group); rats treated with anti-EMMPRIN monoclonal antibody immediately after modelling and sacrificed at 24 h (SAH-inhibition group).
MEASUREMENT OF BRAIN WATER CONTENT
Rats were killed by decapitation under deep 30 mg/kg pentobarbital i.v. anaesthesia. Brains were removed rapidly and a coronal slice (3 mm thick) was taken 3 mm from the frontal pole. The slice of brain along the midline and cortex was separated bilaterally from the basal ganglia. The method of vacuum freeze-drying was used for the microdetermination of regional brain water content, as described previously. 23,24 Tissue samples were immediately weighed on an electronic analytical balance (model T-214; Denver Instrument Co., Arvada, CO, USA) to obtain the wet weight (WW), then dried for 48 h in a Leybold vacuum freeze-drying apparatus (Leybold-Heraeus, Hanau, Germany) and reweighed to obtain the dry weight (DW). Brain water content was calculated using the following equation:
QUANTITATIVE REAL-TIME RT-PCR ASSAY OF EMMPRIN MRNA
Levels of EMMPRIN mRNA in brain tissue from rats in each group were detected by quantitative real-time reverse transcriptionpolymerase chain reaction (RT-PCR). Frozen brain tissue (50 -80 mg) was used for total RNA extraction using TRIzol ® reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.
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Quantitative real-time RT-PCR was carried out on an ABI PRISM ® 7700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) using the One-Step SYBR ® PrimeScript™ RT-PCR Kit (Takara Bio, Shiga, Japan). The following primers were used: EMMPRIN -forward 5′-TGGCCTTCACGT TCCTGAGT-3′ and reverse 5′-GTCATCTGCA TCCACCGTGT-3′ (215 base pair [bp] fragment); β-actin control -forward 5′-GTGCCACCAGACAGCACTGTGTTG-3′ and reverse 5′-TGGAGAAGAGCTATGAGCTGC CTG-3′ (202 bp fragment). The cycling program involved RT at 42°C for 5 min and 95°C for 10 s, followed by 40 cycles of PCR at 95°C for 5 s and 60°C for 30 s. Productspecific amplification was confirmed by melting-curve analysis and agarose gel electrophoresis. The comparative 2 ∆∆CT method was used for quantification of PCR products. 25 Serial dilutions were made using previously generated PCR products, assigned arbitrary values corresponding to the dilutions, and used to construct relative standard curves for EMMPRIN. Targets were normalized using β-actin as an internal standard.
WESTERN BLOT ANALYSIS OF EMMPRIN PROTEIN
Frozen brain tissue (20 mg/sample) was homogenized in lysis buffer containing 10 mM phosphate-buffered saline, pH 7.4, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecylsulphate (SDS), 100 µg/ml aprotinin, 100 µg/ml phenylmethylsulphonyl fluoride (PMSF) and 0.1 mM sodium orthovanadate, at 4°C, and sonicated for 70 s. Then, 5 µl of 100 µg/ml PMSF was added, it was left on ice for 30 min, followed by centrifugation at 20 817 g for 20 min at 4°C. The protein content of the supernatant was measured using the Bradford method, with bovine serum albumin used as a standard. Equal amounts of protein (30 µg) were boiled with 2 × sample buffer containing 5% βmercaptoethanol for 5 min, separated on a 15% polyacrylamide gel under SDS denaturing conditions, and transferred to a nitrocellulose membrane at 90 V for 2 h. The nitrocellulose membranes were stained with Ponceau S to assess the efficiency of protein transfer. The membranes were blocked with 5% nonfat dry milk in 0.05% Tween-20 and 1 × Tris-HCl-buffered saline overnight at 4°C. They were then washed three times, each time for 10 min using 25 mM Tris buffer with 0.1% Tween-20 (TBST, pH 7.4) and incubated with a polyclonal rabbit antirat EMMPRIN antibody (1:1000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 1 h at room temperature. After washing three times, each time for 10 min using TBST, the membranes were incubated with a horseradish peroxidase-labelled goat antirabbit IgG (1:500 dilution; Sigma-Aldrich, St Louis, MO, USA) for 1 h at room temperature. After again washing three times, each time for 10 min using TBST, the protein signal was detected by enhanced chemiluminescence (Amersham ECL system; GE Healthcare Life Sciences, Little Chalfont, UK). A polyclonal rabbit antibody to the housekeeping protein β-actin (1:1000 dilution; Santa Cruz Biotechnology) was used as a loading control. The procedure and secondary antibody used to detect βactin were the same as those described for the EMMPIRIN antibody. Positive immunoreactive bands were quantified densitometrically (Leica Q500IW Image Analysis System; Leica, Solms, Germany) and expressed as a ratio of EMMPRIN to β-actin in optical density units.
STATISTICAL ANALYSES
The SPSS ® statistical software, version 13.0 Y Tu, J Fu, J Wang et al. EMMPRIN in brain oedema (SPSS Inc., Chicago, IL, USA) for Windows ® was used for statistical analyses. Data were expressed as mean ± SD. Differences between the subarachnoid haemorrhage modelling and inhibition groups versus the shamoperated group were analysed by one-way analysis of variance, with post hoc Tukey's test applied for paired comparisons. A difference between means was considered significant if the P-value was < 0.05.
Results
No significant differences were observed between the groups for physiological parameters (including blood gases, blood pH, haematocrit, blood glucose concentration and body temperature) which were all within normal ranges at the time of subarachnoid haemorrhage modelling (Table 1) .
Increased mean levels of EMMPRIN mRNA in brain tissue were observed in the SAH-12, SAH-24 and SAH-72 groups (P < 0.05, P < 0.01, P < 0.05, respectively versus the sham group); maximal in the SAH-24 group (Fig. 1) . Similar results for mean EMMPRIN protein levels were observed in these groups (Fig. 2) . Administration of the anti-EMMPRIN monoclonal antibody immediately after modelling in the SAHinhibition group significantly reduced mean levels of EMMPRIN mRNA and protein at 24 h (P < 0.05 versus SAH-24 group; Figs 1 and  2) .
Compared with the sham group, a significant increase (P < 0.05) in mean brain water content was detected from 12 h after subarachnoid haemorrhage modelling (Fig.  3) . The mean brain water content was maximal at 24 h after modelling (P < 0.01, SAH-24 versus sham group); declining slightly from its peak by 72 h (P < 0.05, SAH-72 versus sham group). 
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immediately after modelling in the SAHinhibition group significantly reduced brain water content at 24 h (P < 0.05 versus SAH-24 group; Fig. 3 ).
Discussion
The present study investigated the relationship between EMMPRIN mRNA and protein levels and severity of brain oedema induced by subarachnoid haemorrhage. Brain oedema has been recognized as a primary cause of mortality in patients with subarachnoid haemorrhage, 26 with more immediate pathological processes occurring before the onset of vasospasm. 27 The present study demonstrated that EMMPRIN may play an important role in brain oedema formation induced by subarachnoid haemorrhage.
The integrity of the blood-brain barrier contributes to protection of the neuronal microenvironment. Proteolytic enzyme remodelling of extracellular material plays a crucial role in a variety of physiological and pathophysiological conditions. 28 MMPs (a family of calcium-requiring and zinccontaining proteolytic enzymes) degrade the molecules of the extracellular matrix. 29 EMMPRIN is a transmembrane glycoprotein and a member of the IgG superfamily of receptors that induces MMPs; 30 it is involved in many physiological processes and pathological conditions, such as tumour invasion, ovulation, spermatogenesis and inflammatory reactions. 31 -33 EMMPRIN can induce MMP-1, MMP-2 and MMP-3 in human fibroblasts, and also increases FIGURE 1: Brain tissue levels of extracellular matrix metalloproteinase inducer (EMMPRIN) mRNA, assessed by quantitative real-time reverse transcriptionpolymerase chain reaction, in male Sprague-Dawley rats (n = 20 per group) sacrificed at 12, 24 or 72 h after subarachnoid haemorrhage induction (SAH-12, SAH-24 and SAH-72 groups, respectively); or treated with EMMPRIN inhibitor immediately after subarachnoid haemorrhage and sacrificed at 24 h (SAH-inhibition group); or control rats, sacrificed immediately after sham surgery (sham group). EMMPRIN mRNA was measured relative to β-actin mRNA as an internal standard and expressed as a ratio. Data presented as mean ± SD. a P < 0.05 and b P < 0.01 versus sham group; c P < 0.05 versus SAH-24 group; one-way analysis of variance with post hoc Tukey's test 34 The particular structural features of EMMPRIN suggest that it is involved in protein-protein interactions. EMMPRIN is preferentially located in capillaries of the brain, and has been proposed as an important molecule in the blood-brain barrier. 35, 36 Evidence also indicates that EMMPRIN is expressed in vascular endothelial cells of the central nervous system with an intact blood-brain barrier. 37 The mechanism of the blood-brain barrier is mainly based on tight junctions, formed among neighbouring nonfenestrated endothelial cells. It has been suggested that the interaction between endothelial and astroglial cells might involve EMMPRIN activity. 38 It is still unclear, however, how EMMPRIN is related to blood-brain barrier function. EMMPRIN can serve as a receptor for interactions with extracellular molecules that stimulate signal transduction pathways, culminating in the transcriptional activation of MMPs. 39, 40 Taken together, these findings suggest the importance of EMMPRIN in the progression of brain damage caused by blood-brain barrier disruption.
Previous studies on brain oedema in subarachnoid haemorrhage were concerned mainly with the morphological effects of oedema. 26 Brain oedema was quantitatively documented in the present study, using the method of vacuum freeze-drying for microdetermination of regional brain water content. 23,24 After subarachnoid haemorrhage 
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modelling, brain water content was maximal at 24 h, declining slightly from its peak by 72 h, which suggests that brain water content is related to the severity of induced brain oedema. EMMPRIN mRNA and protein were detected in brain tissue at 12 h and were maximal at 24 h, falling slightly by 72 h after modelling: levels for all three groups were significantly higher than for the sham group. These results are identical to those reported by Burggraf et al. 41 who showed increased EMMPRIN expression in rat brain following cerebral ischaemia. Furthermore, inhibition of EMMPRIN activity may relieve the aggravation of brain oedema after SAH.
In conclusion, the present study provides new insights into molecular mechanisms involved in the formation and progression of brain oedema after subarachnoid haemorrhage.
The upregulation of EMMPRIN may play an important role in the formation of brain oedema induced by subarachnoid haemorrhage, and the inhibition of EMMPRIN activity may provide a potential approach to reduce ongoing oedema after subarachnoid haemorrhage. A future goal of experimental studies will be to confirm directly the role of EMMPRIN in subarachnoid haemorrhage using EMMPRIN-knockout rats with this condition.
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